Local Institution - 301

Pavia 27100

0 studies enrolling now · 2 studies all time

What they study most

Anemia, Lymphoma, Primary Myelofibrosis

Studies at this site

• A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas — Stopped early
• A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence — Completed